Free Trial
→ Drop these 5 stocks before the market opens tomorrow! (From Weiss Ratings) (Ad)tc pixel Free HYLN Stock Alerts

Hyliion (HYLN) Financials

Hyliion logo
$2.47 -0.22 (-8.18%)
Closing price 11/13/2026 04:10 PM Eastern
Extended Trading
$2.47 0.00 (0.00%)
As of 11/13/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Hyliion

Annual Income Statements for Hyliion

This table shows Hyliion's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -14 324 -96 -153 -124 -52 -57
Consolidated Net Income / (Loss)		 -14 324 -96 -153 -124 -52 -57
Net Income / (Loss) Continuing Operations		 -14 324 -96 -153 -124 -52 -57
Total Pre-Tax Income 		-14 324 -96 -153 -124 -52 -57
Total Revenue		 -3.26 -16 0.98 7.83 14 14 12
Net Interest Income / (Expense)		 -3.26 -5.46 0.78 5.72 14 12 8.35
Total Interest Income		 0.00 0.01 0.78 5.72 14 12 8.35
Investment Securities Interest Income		 0.00 0.01 0.78 5.72 14 12 8.35
Total Interest Expense		 3.26 5.47 0.00 0.00 0.00 0.00 0.00
Total Non-Interest Income		 0.00 -10 0.20 2.11 0.67 1.51 3.49
Service Charges on Deposit Accounts		 - - - 0.00 - 0.00 0.00
Net Realized & Unrealized Capital Gains on Investments		 0.00 -10 0.00 - 0.00 0.00 0.01
Other Non-Interest Income		 0.00 0.00 0.20 2.11 0.67 1.51 3.48
Total Non-Interest Expense		 11 -340 97 161 138 66 69
Marketing Expense		 9.27 13 58 110 82 37 42
Other Operating Expenses		 2.73 9.59 38 51 44 26 26
Restructuring Charge		 - - - 0.00 11 3.01 0.50
Nonoperating Income / (Expense), net		 - -0.01 - -0.03 - 0.03 0.00
Basic Earnings per Share		 ($0.16) $3.11 ($0.56) ($0.87) ($0.68) ($0.30) ($0.33)
Weighted Average Basic Shares Outstanding		 86.64M 104.32M 172.22M 175.40M 181.41M 174.92M 175.43M
Diluted Earnings per Share		 ($0.16) ($0.35) ($0.56) ($0.87) ($0.68) ($0.30) ($0.33)
Weighted Average Diluted Shares Outstanding		 86.64M 112.57M 172.22M 175.40M 181.41M 174.92M 175.43M
Weighted Average Basic & Diluted Shares Outstanding		 86.64M 170.26M 173.57M 179.99M 183.21M 174.82M 177.81M

Quarterly Income Statements for Hyliion

This table shows Hyliion's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -30 -29 -16 -11 -11 -14 -17 -13 -13 -13 -12
Consolidated Net Income / (Loss)		 -30 -29 -16 -11 -11 -14 -17 -13 -13 -13 -12
Net Income / (Loss) Continuing Operations		 -30 -29 -16 -11 -11 -14 -17 -13 -13 -13 -12
Total Pre-Tax Income 		-30 -29 -16 -11 -11 -14 -17 -13 -13 -13 -12
Total Revenue		 3.63 3.46 3.40 3.13 2.98 4.22 2.96 3.72 2.72 2.44 4.32
Net Interest Income / (Expense)		 3.53 3.46 3.40 3.13 2.98 2.71 2.47 2.21 1.96 1.71 1.49
Total Interest Income		 3.53 3.46 3.40 3.13 2.98 2.71 2.47 2.21 1.96 1.71 1.49
Investment Securities Interest Income		 3.53 3.46 3.40 3.13 2.98 2.71 2.47 2.21 1.96 1.71 1.49
Total Interest Expense		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Non-Interest Income		 0.10 - 0.00 0.00 0.00 1.51 0.49 1.52 0.76 0.73 2.83
Service Charges on Deposit Accounts		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Other Non-Interest Income		 0.10 - 0.00 0.00 0.00 1.51 0.49 1.52 0.76 0.71 2.83
Total Non-Interest Expense		 34 33 19 14 14 19 20 17 16 16 16
Marketing Expense		 25 8.77 7.97 8.31 9.46 11 12 10 10 9.96 7.67
Other Operating Expenses		 8.86 12 6.59 6.26 5.65 7.30 6.56 7.35 5.99 6.17 8.80
Restructuring Charge		 0.00 11 4.43 -0.56 -0.93 0.06 1.42 -0.35 -0.07 -0.51 -0.41
Basic Earnings per Share		 ($0.17) ($0.16) ($0.09) ($0.06) ($0.06) ($0.09) ($0.10) ($0.08) ($0.08) ($0.07) ($0.07)
Weighted Average Basic Shares Outstanding		 181.64M 181.41M 178.48M 173.83M 173.61M 174.92M 174.34M 175.31M 175.65M 175.43M 177.67M
Diluted Earnings per Share		 ($0.17) ($0.16) ($0.09) ($0.06) ($0.06) ($0.09) ($0.10) ($0.08) ($0.08) ($0.07) ($0.07)
Weighted Average Diluted Shares Outstanding		 181.64M 181.41M 178.48M 173.83M 173.61M 174.92M 174.34M 175.31M 175.65M 175.43M 177.67M
Weighted Average Basic & Diluted Shares Outstanding		 182.79M 183.21M 174.04M 173.58M 173.73M 174.82M 175.23M 175.44M 175.97M 177.81M 178.33M

Annual Cash Flow Statements for Hyliion

This table details how cash moves in and out of Hyliion's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 5.19 383 -131 -139 -99 -12 14
Net Cash From Operating Activities		 -11 -23 -81 -117 -117 -57 -47
Net Cash From Continuing Operating Activities		 -11 -23 -81 -117 -117 -57 -47
Net Income / (Loss) Continuing Operations		 -14 324 -96 -153 -124 -52 -57
Consolidated Net Income / (Loss)		 -14 324 -96 -153 -124 -52 -57
Depreciation Expense		 1.03 0.85 0.88 1.23 3.51 3.15 5.96
Amortization Expense		 2.49 4.24 1.82 1.25 -2.87 -3.08 -1.56
Non-Cash Adjustments to Reconcile Net Income		 0.22 -351 5.83 36 8.85 9.87 7.81
Changes in Operating Assets and Liabilities, net		 -0.69 -1.60 7.02 -1.84 -2.95 -15 -1.57
Net Cash From Investing Activities		 -0.35 -238 -66 -22 18 59 61
Net Cash From Continuing Investing Activities		 -0.35 -238 -66 -22 18 59 61
Purchase of Property, Leasehold Improvements and Equipment		 -0.35 -0.31 -2.38 -2.89 -7.40 -17 -24
Purchase of Investment Securities		 0.00 -238 -318 -283 -190 -96 -46
Sale of Property, Leasehold Improvements and Equipment		 0.00 0.02 0.05 0.15 0.00 5.39 2.23
Sale and/or Maturity of Investments		 0.00 0.00 254 264 215 167 129
Other Investing Activities, net		 0.00 0.00 -0.03 0.00 -0.05 0.00 0.04
Net Cash From Financing Activities		 17 645 16 -0.08 -0.02 -14 -0.67
Net Cash From Continuing Financing Activities		 17 645 16 -0.08 -0.02 -14 -0.67
Repurchase of Common Equity		 - - - 0.00 -0.03 -14 0.00
Other Financing Activities, Net		 0.01 516 0.59 -0.08 0.02 -0.35 -0.67

Quarterly Cash Flow Statements for Hyliion

This table details how cash moves in and out of Hyliion's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 -20 -7.80 -6.08 4.42 8.93 -19 3.11 3.26 2.29 5.06 -2.68
Net Cash From Operating Activities		 -29 -25 -23 -11 -9.90 -13 -14 -10.00 -11 -12 -13
Net Cash From Continuing Operating Activities		 -29 -25 -23 -11 -9.90 -13 -14 -10.00 -11 -12 -13
Net Income / (Loss) Continuing Operations		 -30 -29 -16 -11 -11 -14 -17 -13 -13 -13 -12
Consolidated Net Income / (Loss)		 -30 -29 -16 -11 -11 -14 -17 -13 -13 -13 -12
Depreciation Expense		 0.66 1.72 0.57 0.71 0.86 1.01 1.14 1.29 1.64 1.89 2.11
Amortization Expense		 -1.03 -1.05 -0.97 -0.87 -0.65 -0.59 -0.58 -0.42 -0.27 -0.30 -0.25
Non-Cash Adjustments to Reconcile Net Income		 2.58 1.62 6.39 1.39 0.51 1.58 3.13 1.55 1.75 1.39 1.54
Changes in Operating Assets and Liabilities, net		 -0.73 2.31 -13 -1.08 0.60 -1.05 -0.45 1.00 -0.47 -1.65 -4.39
Net Cash From Investing Activities		 9.10 17 28 18 19 -5.37 18 13 13 17 10
Net Cash From Continuing Investing Activities		 9.10 17 28 18 19 -5.37 18 13 13 17 10
Purchase of Property, Leasehold Improvements and Equipment		 -2.80 -0.65 -2.82 -5.24 -2.49 -5.98 -7.33 -4.24 -10 -1.74 -1.87
Purchase of Investment Securities		 -71 -19 -24 -8.92 -23 -41 0.00 -18 -18 -10 -15
Sale of Property, Leasehold Improvements and Equipment		 - - 0.57 2.90 0.64 1.28 0.22 0.58 0.39 1.04 1.60
Sale and/or Maturity of Investments		 83 37 54 29 43 40 25 35 41 28 26
Other Investing Activities, net		 - - 0.00 - - - 0.04 - - - 0.00
Net Cash From Financing Activities		 0.13 -0.01 -11 -3.01 -0.01 -0.02 -0.44 -0.09 -0.06 -0.08 0.00
Net Cash From Continuing Financing Activities		 0.13 -0.01 -11 -3.01 -0.01 -0.02 -0.44 -0.09 -0.06 -0.08 0.00
Other Financing Activities, Net		 0.13 0.02 -0.25 -0.07 -0.01 -0.02 -0.44 -0.09 -0.06 -0.08 0.00

Annual Balance Sheets for Hyliion

This table presents Hyliion's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 0.40 14 655 578 447 328 263 204
Cash and Due from Banks		 0.00 6.29 390 258 119 13 9.23 23
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net		 - 1.64 1.17 2.24 5.61 9.99 26 40
Other Assets		 0.00 5.75 264 318 321 306 228 140
Total Liabilities & Shareholders' Equity		 0.40 14 655 578 447 328 263 204
Total Liabilities		 0.38 32 15 25 23 22 19 12
Short-Term Debt		 0.07 7.88 2.62 7.46 3.15 5.07 7.67 5.87
Accrued Interest Payable		 0.30 - - - 12 - 6.62 4.00
Other Long-Term Liabilities		 0.00 5.30 5.25 17 8.49 7.00 4.37 1.69
Commitments & Contingencies		 - 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 0.02 -18 640 554 424 306 244 192
Total Preferred & Common Equity		 0.02 -18 640 554 424 306 244 192
Total Common Equity		 0.02 -18 640 554 424 306 244 192
Common Stock		 0.03 31 365 375 398 404 408 413
Retained Earnings		 -0.00 -49 275 179 26 -98 -150 -207
Treasury Stock		 - - - - 0.00 -0.03 -14 -14

Quarterly Balance Sheets for Hyliion

This table presents Hyliion's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 391 356 298 281 272 241 229 216 191
Cash and Due from Banks		 48 29 15 19 28 12 16 18 20
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net		 8.94 11 13 16 17 29 33 42 38
Other Assets		 334 316 270 246 227 199 181 157 132
Total Liabilities & Shareholders' Equity		 391 356 298 281 272 241 229 216 191
Total Liabilities		 28 22 17 14 15 13 13 12 9.03
Short-Term Debt		 2.86 4.31 3.56 2.03 3.19 4.00 5.26 4.70 3.71
Accrued Interest Payable		 - - 6.95 5.49 5.98 5.24 5.00 5.29 4.37
Other Long-Term Liabilities		 9.34 8.60 6.74 6.01 5.40 3.75 3.08 2.39 0.95
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 363 334 280 268 258 228 216 204 182
Total Preferred & Common Equity		 363 334 280 268 258 228 216 204 182
Total Common Equity		 363 334 280 268 258 228 216 204 182
Common Stock		 401 403 405 406 407 409 410 412 415
Retained Earnings		 -38 -69 -113 -124 -135 -167 -180 -194 -219
Treasury Stock		 - - -11 -14 -14 -14 -14 -14 -14

Annual Metrics And Ratios for Hyliion

This table displays calculated financial ratios and metrics derived from Hyliion's official financial filings.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 29,126,147.00 153,901,829.00 173,313,427.00 179,714,124.00 182,789,454.00 - 175,974,228.00
DEI Adjusted Shares Outstanding		 29,126,147.00 153,901,829.00 173,313,427.00 179,714,124.00 182,789,454.00 - 175,974,228.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.48 2.11 -0.55 -0.85 -0.68 - -0.33
Growth Metrics		 - - - - - - -
Revenue Growth		 0.00% -379.42% 106.26% 699.80% 84.94% -5.20% -13.75%
EBITDA Growth		 0.00% 3,197.92% -128.35% -61.58% 18.51% 57.69% -1.51%
EBIT Growth		 0.00% 2,392.28% -129.63% -59.61% 19.40% 57.85% -9.81%
NOPAT Growth		 0.00% 3,374.69% -120.74% -59.61% 19.40% 57.85% -9.81%
Net Income Growth		 0.00% 2,396.58% -129.63% -59.67% 19.46% 57.86% -9.88%
EPS Growth		 0.00% -118.75% -60.00% -55.36% 21.84% 55.88% -10.00%
Operating Cash Flow Growth		 0.00% -107.23% -250.86% -45.19% -0.07% 51.49% 17.96%
Free Cash Flow Firm Growth		 0.00% 0.00% 104.72% 81.07% 5.70% -21.01% -38.00%
Invested Capital Growth		 0.00% 126,068.69% -12.79% -23.99% -27.04% -19.04% -21.50%
Revenue Q/Q Growth		 0.00% 0.00% 110.19% 77.71% -2.55% 5.85% -13.08%
EBITDA Q/Q Growth		 0.00% 0.00% -133.68% -0.05% 0.39% 21.82% 4.32%
EBIT Q/Q Growth		 0.00% 0.00% -134.93% 0.19% 0.14% 22.09% 2.08%
NOPAT Q/Q Growth		 0.00% 0.00% -124.33% 0.19% 0.14% 22.03% 2.08%
Net Income Q/Q Growth		 0.00% 0.00% -134.75% 0.16% 0.21% 22.06% 2.08%
EPS Q/Q Growth		 0.00% 0.00% -7.69% 2.25% 0.00% 18.92% 5.71%
Operating Cash Flow Q/Q Growth		 0.00% -9.13% -30.30% -2.41% 7.07% 16.35% 3.30%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 117.56% -4.83% 1.19% -26.39% 23.26%
Invested Capital Q/Q Growth		 0.00% 182.62% -4.87% -5.98% -8.07% -3.39% -5.12%
Profitability Metrics		 - - - - - - -
EBITDA Margin		 0.00% 0.00% -9,535.04% -1,926.30% -848.82% -378.87% -445.90%
EBIT Margin		 0.00% 0.00% -9,810.83% -1,957.93% -853.26% -379.37% -483.01%
Profit (Net Income) Margin		 0.00% 0.00% -9,810.83% -1,958.58% -852.91% -379.14% -483.01%
Tax Burden Percent		 99.81% 100.00% 100.00% 100.01% 99.96% 100.00% 100.00%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.02% 100.00% 99.94% 100.00%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% -11.16% -21.72% -23.44% -12.94% -17.79%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% -535.68% -890.29% -924.34% -257.71% -271.27%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% -4.93% -9.66% -10.41% -5.96% -8.41%
Return on Equity (ROE)		 78.11% 104.20% -16.09% -31.38% -33.85% -18.90% -26.21%
Cash Return on Invested Capital (CROIC)		 0.00% -49.73% 2.51% 5.53% 7.83% 8.10% 6.29%
Operating Return on Assets (OROA)		 0.00% 0.00% -15.57% -29.91% -31.88% -17.61% -24.51%
Return on Assets (ROA)		 0.00% 0.00% -15.57% -29.92% -31.87% -17.60% -24.51%
Return on Common Equity (ROCE)		 78.11% 104.20% -16.09% -31.38% -33.85% -18.90% -26.21%
Return on Equity Simple (ROE_SIMPLE)		 78.11% 50.63% -17.34% -36.21% -40.33% -21.30% -29.78%
Net Operating Profit after Tax (NOPAT)		 -9.90 324 -67 -107 -86 -36 -40
NOPAT Margin		 0.00% 0.00% -6,867.58% -1,370.55% -597.28% -265.56% -338.10%
Net Nonoperating Expense Percent (NNEP)		 24.01% 0.11% 524.52% 868.57% 900.90% 244.77% 253.47%
SG&A Expenses to Revenue		 0.00% 0.00% 5,951.07% 1,409.58% 567.92% 269.55% 358.67%
Operating Expenses to Revenue		 0.00% 0.00% 9,910.83% 2,057.93% 953.26% 479.37% 583.01%
Earnings before Interest and Taxes (EBIT)		 -14 324 -96 -153 -124 -52 -57
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -11 329 -93 -151 -123 -52 -53
Valuation Ratios		 - - - - - - -
Price to Book Value (P/BV)		 0.00 3.96 1.94 0.99 0.49 1.86 1.69
Price to Tangible Book Value (P/TBV)		 0.00 3.96 1.94 0.99 0.49 1.86 1.69
Price to Revenue (P/Rev)		 0.00 0.00 1,097.59 53.71 10.27 33.03 27.35
Price to Earnings (P/E)		 0.00 7.83 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 12.78% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 3.34 1.47 0.71 0.45 1.79 1.55
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 841.22 38.85 9.73 32.92 25.91
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 6.53 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 6.63 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 6.63 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 54.55 11.13 4.88 19.80 21.68
Leverage & Solvency		 - - - - - - -
Debt to Equity		 -0.97 0.01 0.01 0.01 0.02 0.03 0.03
Long-Term Debt to Equity		 -0.54 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.97 0.03 0.01 0.01 0.01 0.02 0.03
Leverage Ratio		 -0.78 1.08 1.03 1.05 1.06 1.07 1.07
Compound Leverage Factor		 -0.78 1.08 1.03 1.05 1.06 1.07 1.07
Debt to Total Capital		 -3,436.01% 0.55% 1.33% 0.74% 1.63% 3.04% 2.97%
Short-Term Debt to Total Capital		 -1,541.29% 0.41% 1.33% 0.74% 1.63% 3.04% 2.97%
Long-Term Debt to Total Capital		 -1,894.72% 0.14% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 3,536.01% 99.45% 98.67% 99.26% 98.37% 96.96% 97.03%
Debt to EBITDA		 -1.65 0.01 -0.08 -0.02 -0.04 -0.15 -0.11
Net Debt to EBITDA		 -1.06 -1.17 2.69 0.77 0.06 0.03 0.32
Long-Term Debt to EBITDA		 -0.91 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 -1.77 0.01 -0.11 -0.03 -0.06 -0.21 -0.15
Net Debt to NOPAT		 -1.14 -1.19 3.73 1.08 0.09 0.04 0.43
Long-Term Debt to NOPAT		 -0.98 0.00 0.00 0.00 0.00 0.00 0.00
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - -
Cash Flow Metrics		 - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -320 15 27 29 23 14
Operating Cash Flow to CapEx		 -3,172.49% -7,939.10% -3,447.62% -4,276.51% -1,580.78% -509.32% -216.45%
Free Cash Flow to Firm to Interest Expense		 0.00 -58.57 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 -3.40 -4.20 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 -3.50 -4.25 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.02 0.04 0.05 0.05
Fixed Asset Turnover		 0.00 0.00 0.57 2.00 1.86 0.76 0.36
Capital & Investment Metrics		 - - - - - - -
Invested Capital		 -0.51 644 561 427 311 252 198
Invested Capital Turnover		 0.00 0.00 0.00 0.02 0.04 0.05 0.05
Increase / (Decrease) in Invested Capital		 0.00 644 -82 -135 -115 -59 -54
Enterprise Value (EV)		 302 2,150 824 304 141 452 307
Market Capitalization		 291 2,536 1,075 421 149 453 324
Book Value per Share		 ($0.62) $4.16 $3.20 $2.36 $1.68 $1.41 $1.09
Tangible Book Value per Share		 ($0.64) $4.16 $3.19 $2.36 $1.68 $1.41 $1.09
Total Capital		 -0.51 644 561 427 311 252 198
Total Debt		 18 3.53 7.46 3.15 5.07 7.67 5.87
Total Long-Term Debt		 9.68 0.91 0.00 0.00 0.00 0.00 0.00
Net Debt		 11 -386 -251 -116 -7.81 -1.56 -17
Capital Expenditures (CapEx)		 0.35 0.29 2.34 2.73 7.40 11 22
Net Nonoperating Expense (NNE)		 4.22 0.01 29 46 37 16 17
Net Nonoperating Obligations (NNO)		 18 3.53 7.46 3.15 5.07 7.67 5.87
Total Depreciation and Amortization (D&A)		 3.51 5.09 2.70 2.48 0.64 0.07 4.39
Earnings Adjustments		 - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 ($0.56) ($0.87) ($0.68) ($0.30) ($0.33)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 172.22M 175.40M 181.41M 174.92M 175.43M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 ($0.56) ($0.87) ($0.68) ($0.30) ($0.33)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 172.22M 175.40M 181.41M 174.92M 175.43M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 173.57M 179.99M 183.21M 174.82M 177.81M
Normalized Net Operating Profit after Tax (NOPAT)		 -11 -26 -67 -107 -78 -34 -40
Normalized NOPAT Margin		 0.00% 0.00% -6,815.38% -1,370.55% -541.81% -250.23% -335.15%
Pre Tax Income Margin		 0.00% 0.00% -9,810.83% -1,958.34% -853.26% -379.14% -483.01%
Debt Service Ratios		 - - - - - - -
EBIT to Interest Expense		 -4.34 59.31 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 -3.04 59.31 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 -4.44 59.26 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 -3.14 59.26 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% -0.03% -26.86% 0.00%

Quarterly Metrics And Ratios for Hyliion

This table displays calculated financial ratios and metrics derived from Hyliion's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 181,220,377.00 182,789,454.00 182,789,454.00 174,035,799.00 173,583,438.00 - 174,820,174.00 175,232,794.00 175,436,636.00 175,974,228.00 177,812,784.00
DEI Adjusted Shares Outstanding		 181,220,377.00 182,789,454.00 182,789,454.00 174,035,799.00 173,583,438.00 - 174,820,174.00 175,232,794.00 175,436,636.00 175,974,228.00 177,812,784.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.17 -0.16 -0.09 -0.06 -0.06 - -0.10 -0.08 -0.08 -0.07 -0.07
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 46.90% -9.86% -9.94% -13.42% -17.93% 21.89% -13.00% 19.02% -8.73% -42.19% 46.16%
EBITDA Growth		 51.14% 1.67% 43.86% 68.65% 64.20% 50.94% -4.34% -13.62% -8.80% 17.05% 40.82%
EBIT Growth		 52.12% 0.58% 45.89% 69.09% 63.09% 50.63% -10.66% -23.20% -19.06% 8.44% 31.98%
NOPAT Growth		 52.12% 0.59% 45.89% 69.09% 63.09% 50.68% -10.66% -23.20% -19.06% 8.44% 31.98%
Net Income Growth		 52.16% 0.87% 45.92% 69.18% 63.06% 50.57% -10.66% -23.56% -19.06% 8.44% 31.98%
EPS Growth		 52.78% 0.00% 43.75% 68.42% 64.71% 43.75% -11.11% -33.33% -33.33% 22.22% 30.00%
Operating Cash Flow Growth		 -3.47% 26.62% 31.70% 64.76% 65.69% 45.19% 38.31% 6.54% -8.05% 11.82% 9.13%
Free Cash Flow Firm Growth		 2.23% -16.78% -5.45% -18.64% -25.55% -48.18% -62.08% -55.54% -38.47% -8.63% -3.91%
Invested Capital Growth		 -25.38% -27.04% -29.02% -26.27% -22.96% -19.04% -18.30% -18.06% -20.07% -21.50% -20.07%
Revenue Q/Q Growth		 0.44% -4.60% -1.85% -7.94% -4.79% 41.69% -29.95% 25.94% -26.99% -10.26% 77.13%
EBITDA Q/Q Growth		 12.78% 7.22% 43.88% 30.96% 0.40% -27.13% -19.36% 24.82% 4.62% 3.08% 14.85%
EBIT Q/Q Growth		 13.86% 3.89% 46.54% 30.17% -2.88% -28.53% -19.84% 22.26% 0.57% 1.15% 10.97%
NOPAT Q/Q Growth		 13.86% 3.80% 46.59% 30.17% -2.88% -28.53% -19.84% 22.26% 0.57% 1.15% 10.97%
Net Income Q/Q Growth		 13.92% 3.93% 46.47% 30.37% -3.19% -28.53% -19.84% 22.26% 0.57% 1.15% 10.97%
EPS Q/Q Growth		 10.53% 5.88% 43.75% 33.33% 0.00% -50.00% -11.11% 20.00% 0.00% 12.50% 0.00%
Operating Cash Flow Q/Q Growth		 4.98% 14.92% 7.47% 52.89% 7.47% -35.90% -4.14% 28.63% -6.97% -10.91% -7.32%
Free Cash Flow Firm Q/Q Growth		 -13.66% 1.09% 10.81% -15.87% -21.00% -29.63% -18.90% -1.38% 9.34% 4.48% -14.71%
Invested Capital Q/Q Growth		 -7.47% -8.07% -8.79% -4.96% -3.32% -3.39% -7.96% -4.68% -5.69% -5.12% -6.29%
Profitability Metrics		 - - - - - - - - - - -
EBITDA Margin		 -846.17% -822.93% -470.52% -352.86% -369.15% -331.20% -564.32% -336.87% -440.05% -475.29% -228.48%
EBIT Margin		 -836.03% -842.22% -458.72% -347.97% -376.03% -341.10% -583.50% -360.20% -490.51% -540.29% -271.56%
Profit (Net Income) Margin		 -835.32% -841.18% -458.72% -346.95% -376.03% -341.10% -583.50% -360.20% -490.51% -540.29% -271.56%
Tax Burden Percent		 100.00% 99.78% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent		 99.91% 100.10% 100.00% 99.71% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -21.95% -23.16% -13.24% -10.44% -11.39% -11.64% -21.04% -14.26% -19.92% -19.90% -12.03%
ROIC Less NNEP Spread (ROIC-NNEP)		 -284.40% -234.73% -146.19% -142.91% -101.02% -79.44% -158.06% -124.71% -121.46% -78.34% -103.43%
Return on Net Nonoperating Assets (RNNOA)		 -2.50% -2.64% -1.52% -1.11% -1.28% -1.84% -2.35% -1.88% -2.07% -2.43% -1.95%
Return on Equity (ROE)		 -24.45% -25.80% -14.76% -11.54% -12.67% -13.47% -23.38% -16.14% -22.00% -22.33% -13.97%
Cash Return on Invested Capital (CROIC)		 7.21% 7.83% 11.37% 11.31% 10.33% 8.10% 5.57% 3.81% 4.89% 6.29% 4.98%
Operating Return on Assets (OROA)		 -29.83% -31.47% -18.06% -14.10% -15.52% -15.84% -28.79% -19.59% -27.35% -27.42% -16.61%
Return on Assets (ROA)		 -29.80% -31.43% -18.06% -14.06% -15.52% -15.84% -28.79% -19.59% -27.35% -27.42% -16.61%
Return on Common Equity (ROCE)		 -24.45% -25.80% -14.76% -11.54% -12.67% -13.47% -23.38% -16.14% -22.00% -22.33% -13.97%
Return on Equity Simple (ROE_SIMPLE)		 -37.02% 0.00% -39.32% -32.07% -25.91% 0.00% -23.56% -26.07% -28.65% 0.00% -28.43%
Net Operating Profit after Tax (NOPAT)		 -21 -20 -11 -7.62 -7.84 -10 -12 -9.39 -9.34 -9.23 -8.22
NOPAT Margin		 -585.22% -590.14% -321.11% -243.58% -263.22% -238.77% -408.45% -252.14% -343.36% -378.20% -190.09%
Net Nonoperating Expense Percent (NNEP)		 262.46% 211.57% 132.94% 132.48% 89.63% 67.81% 137.03% 110.45% 101.54% 58.43% 91.40%
SG&A Expenses to Revenue		 691.87% 253.19% 234.42% 265.61% 317.62% 266.83% 413.59% 272.21% 372.78% 408.36% 177.46%
Operating Expenses to Revenue		 936.03% 942.22% 558.72% 447.97% 476.03% 441.10% 683.50% 460.20% 590.51% 640.29% 371.56%
Earnings before Interest and Taxes (EBIT)		 -30 -29 -16 -11 -11 -14 -17 -13 -13 -13 -12
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -31 -28 -16 -11 -11 -14 -17 -13 -12 -12 -9.88
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.64 0.49 1.15 1.05 1.67 1.86 1.07 1.07 1.70 1.69 1.72
Price to Tangible Book Value (P/TBV)		 0.64 0.49 1.15 1.05 1.67 1.86 1.07 1.07 1.70 1.69 1.72
Price to Revenue (P/Rev)		 14.39 10.27 22.81 20.70 33.19 33.03 18.42 16.66 25.37 27.35 23.70
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.56 0.45 1.09 0.98 1.55 1.79 1.02 1.00 1.59 1.55 1.60
Enterprise Value to Revenue (EV/Rev)		 12.76 9.73 22.02 19.44 31.27 32.92 17.79 15.92 24.41 25.91 22.45
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 6.64 4.88 7.99 7.37 13.10 19.80 16.44 23.63 28.96 21.68 28.53
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.01 0.02 0.01 0.01 0.01 0.03 0.02 0.02 0.02 0.03 0.02
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 0.01 0.01 0.01 0.01 0.01 0.02 0.01 0.02 0.02 0.03 0.02
Leverage Ratio		 1.06 1.06 1.06 1.07 1.06 1.07 1.06 1.06 1.06 1.07 1.05
Compound Leverage Factor		 1.06 1.06 1.06 1.06 1.06 1.07 1.06 1.06 1.06 1.07 1.05
Debt to Total Capital		 1.27% 1.63% 1.25% 0.75% 1.22% 3.04% 1.72% 2.38% 2.25% 2.97% 2.00%
Short-Term Debt to Total Capital		 1.27% 1.63% 1.25% 0.75% 1.22% 3.04% 1.72% 2.38% 2.25% 2.97% 2.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 98.73% 98.37% 98.75% 99.25% 98.78% 96.96% 98.28% 97.62% 97.75% 97.03% 98.00%
Debt to EBITDA		 -0.04 -0.04 -0.03 -0.02 -0.05 -0.15 -0.08 -0.10 -0.09 -0.11 -0.08
Net Debt to EBITDA		 0.20 0.06 0.10 0.20 0.37 0.03 0.16 0.19 0.24 0.32 0.36
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 -0.05 -0.06 -0.05 -0.03 -0.07 -0.21 -0.11 -0.13 -0.11 -0.15 -0.10
Net Debt to NOPAT		 0.28 0.09 0.14 0.28 0.53 0.04 0.22 0.26 0.32 0.43 0.46
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 94 95 105 89 70 49 40 39 43 45 38
Operating Cash Flow to CapEx		 -1,028.83% -3,797.99% -1,010.77% -457.40% -533.71% -285.98% -196.82% -273.09% -106.54% -1,706.19% -4,610.87%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.04 0.04 0.04 0.04 0.04 0.05 0.05 0.05 0.06 0.05 0.06
Fixed Asset Turnover		 1.76 1.86 1.34 1.10 0.91 0.76 0.63 0.57 0.46 0.36 0.39
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 339 311 284 270 261 252 232 221 209 198 185
Invested Capital Turnover		 0.04 0.04 0.04 0.04 0.04 0.05 0.05 0.06 0.06 0.05 0.06
Increase / (Decrease) in Invested Capital		 -115 -115 -116 -96 -78 -59 -52 -49 -52 -54 -47
Enterprise Value (EV)		 190 141 311 265 406 452 236 221 332 307 296
Market Capitalization		 214 149 322 282 430 453 245 231 346 324 313
Book Value per Share		 $1.85 $1.68 $1.57 $1.54 $1.48 $1.41 $1.30 $1.23 $1.16 $1.09 $1.02
Tangible Book Value per Share		 $1.84 $1.68 $1.57 $1.54 $1.48 $1.41 $1.30 $1.23 $1.16 $1.09 $1.02
Total Capital		 339 311 284 270 261 252 232 221 209 198 185
Total Debt		 4.31 5.07 3.56 2.03 3.19 7.67 4.00 5.26 4.70 5.87 3.71
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -24 -7.81 -11 -17 -25 -1.56 -8.33 -10 -13 -17 -17
Capital Expenditures (CapEx)		 2.80 0.65 2.25 2.34 1.85 4.70 7.12 3.66 10 0.70 0.28
Net Nonoperating Expense (NNE)		 9.08 8.69 4.68 3.23 3.36 4.32 5.18 4.02 4.00 3.95 3.52
Net Nonoperating Obligations (NNO)		 4.31 5.07 3.56 2.03 3.19 7.67 4.00 5.26 4.70 5.87 3.71
Total Depreciation and Amortization (D&A)		 -0.37 0.67 -0.40 -0.15 0.21 0.42 0.57 0.87 1.37 1.59 1.86
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.17) ($0.16) ($0.09) ($0.06) ($0.06) ($0.09) ($0.10) ($0.08) ($0.08) ($0.07) ($0.07)
Adjusted Weighted Average Basic Shares Outstanding		 181.64M 181.41M 178.48M 173.83M 173.61M 174.92M 174.34M 175.31M 175.65M 175.43M 177.67M
Adjusted Diluted Earnings per Share		 ($0.17) ($0.16) ($0.09) ($0.06) ($0.06) ($0.09) ($0.10) ($0.08) ($0.08) ($0.07) ($0.07)
Adjusted Weighted Average Diluted Shares Outstanding		 181.64M 181.41M 178.48M 173.83M 173.61M 174.92M 174.34M 175.31M 175.65M 175.43M 177.67M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 182.79M 183.21M 174.04M 173.58M 173.73M 174.82M 175.23M 175.44M 175.97M 177.81M 178.33M
Normalized Net Operating Profit after Tax (NOPAT)		 -21 -12 -7.81 -8.01 -8.49 -10 -11 -9.63 -9.38 -9.58 -8.51
Normalized NOPAT Margin		 -585.22% -358.21% -229.85% -256.02% -285.05% -237.76% -374.76% -258.65% -345.16% -392.77% -196.80%
Pre Tax Income Margin		 -835.32% -843.06% -458.72% -346.95% -376.03% -341.10% -583.50% -360.20% -490.51% -540.29% -271.56%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% -0.03% -10.04% -16.32% -20.99% -26.86% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Hyliion’s financial statements show a company that remains loss-making but has reduced its quarterly losses from the much larger deficits reported in 2023. In Q1 2026, revenue increased and the net loss narrowed from both Q4 2025 and Q1 2025. However, cash from operations remained negative, and reported revenue was modest relative to operating expenses.

  • Losses have narrowed over the longer term. Hyliion reported a net loss of $11.7 million in Q1 2026, compared with $17.3 million in Q1 2025 and losses above $29 million in Q2–Q4 2023. The improvement has not been consistent every quarter, but the latest result continues the longer-term reduction in losses.
  • Q1 2026 revenue rose. Total revenue was $4.3 million, up from $2.4 million in Q4 2025 and $3.0 million in Q1 2025. The company still reported a net loss, and the figures provided do not show substantial revenue relative to its expense base.
  • Reported liabilities remain low compared with equity. At March 31, 2026, total liabilities were $9.0 million against $181.7 million of equity. Short-term debt was $3.7 million, though liabilities and equity have both changed over time.
  • Investment activity helped offset operating cash outflows. Q1 2026 investing activities provided $10.1 million, including proceeds from investment sales or maturities. These flows can vary with investment timing and should not be mistaken for cash generated by operations.
  • Operating expenses substantially exceed revenue. Q1 2026 non-interest expenses were $16.1 million against $4.3 million of revenue. Marketing expense alone was $7.7 million, with other operating expenses of $8.8 million.
  • Operations continue to consume cash. Net cash used in operating activities was $12.7 million in Q1 2026, compared with $11.9 million in Q4 2025. The quarter’s overall cash balance declined by $2.7 million despite positive investing cash flow.
  • Assets and equity have contracted. Total assets fell to $190.8 million in Q1 2026 from $241.0 million in Q1 2025, while equity declined from $228.0 million to $181.7 million. Retained earnings also became more negative, consistent with continued accumulated losses.
  • Share count has edged higher. Weighted-average basic shares outstanding were about 177.7 million in Q1 2026, compared with 174.3 million in Q1 2025. A rising share count can dilute existing shareholders.
11/14/26 05:40 PM ETAI Generated. May Contain Errors.

Hyliion Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Hyliion's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Hyliion's net income appears to be on a downward trend, with a most recent value of -$57.19 million in 2025, falling from -$14.11 million in 2019. The previous period was -$52.05 million in 2024. Check out Hyliion's forecast to explore projected trends and price targets.

Over the last 6 years, Hyliion's total revenue changed from -$3.26 million in 2019 to $11.84 million in 2025.

In the past 11 quarters, Hyliion's cash and equivalents has ranged from $12.33 million in Q1 2025 to $48.21 million in Q2 2023, and is currently $20.26 million as of their latest financial filing in Q1 2026.

Hyliion had total debt of $5.87 million at the end of 2025, a 23.5% decrease from 2024, and a 66.6% decrease since 2019.

Over the last 6 years, Hyliion's book value per share changed from -0.62 in 2019 to 1.09 in 2025.


Related Companies

Financial statements for NYSEAMERICAN:HYLN last updated on 5/15/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Why I'm selling my Snapback Indicator for just $7
For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...
Base Camp Trading | Sponsoredtc pixel
Every Starlink dish pays this stock
There's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...
Behind the Markets | Sponsoredtc pixel
Your free book is about to disappear
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
My public warning after 55 years of watching the markets
Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...
Weiss Ratings | Sponsoredtc pixel
URGENT: If you own a home, please review the map below.
More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...
Paradigm Press | Sponsoredtc pixel
What the hell is going on?
Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...
Porter & Company | Sponsoredtc pixel
Management just bought 2.8 million shares
Management just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 i...
Monument Traders Alliance | Sponsoredtc pixel
Elon wants to move AI off the planet. Amazon isn't ready.
What if the next AI race isn't on Earth? Tim Bohen's Mission X presentation explores Elon Musk's idea of movin...
StocksToTrade | Sponsoredtc pixel